Download the ELF Test Guide
NAFLD is projected to become the leading cause of liver-related mortality within 20 years.1
As new therapies become available, non-invasive testing is an important tool to help identify patients at risk of developing cirrhosis and liver-related clinical events (LREs). Learn more about the need for noninvasive tests and how the Enhanced Liver Fibrosis (ELF™) Test can help.
